{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T04:55:55Z","timestamp":1790916955745,"version":"4.1.0"},"reference-count":118,"publisher":"Bentham Science Publishers Ltd.","issue":"6","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CDT"],"published-print":{"date-parts":[[2026,6]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>Ferroptosis is a form of oxidative, iron-dependent, non-apoptotic cell death characterized\nby the accumulation of lipid peroxides and the depletion of glutathione. Ferroptosis plays a significant\nrole in human cancer and is essential in neurological disorders, including neurodegeneration,\nstroke, and neurotrauma. One of the key challenges in cancer research is how to effectively kill cancer\ncells while leaving healthy cells intact. Cancer cells often have defects in cell death executioner\nmechanisms, which is one of the main reasons for therapy resistance. To enable growth, cancer cells\nexhibit an increased iron demand compared with normal, non-cancer cells. This iron dependency can\nmake cancer cells more vulnerable to iron-catalyzed necrosis, referred to as ferroptosis. It is a newly\nidentified regulated form of cell death, which is thought to play a major role in neurodegenerative\ndiseases. The mechanisms of ferroptosis in several neurological disorders are discussed in detail in\nthis article. It also provides an overview of emerging medications that target ferroptosis in the treatment\nof neurological disorders. It also highlights the variations and connections between the different\ncell death pathways implicated in neurological disorders. Clarifying the function of ferroptosis in the\nbrain will help us better understand the mechanisms behind neurological disorders and offer possible\nstrategies for both acute and long-term neurological illness prevention and therapy. Consequently,\nwe provide an overview and brief description of the main pathways involved in ferroptosis in this\nreview, focusing on its regulation and its dual roles as a tumor suppressor and an oncogenic process\nin various human malignancies. The identification of FDA-approved drugs as ferroptosis inducers\nhas raised high expectations for ferroptosis as a promising new approach to killing therapy-resistant\ncancers.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/0113894501358981251124065950","type":"journal-article","created":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T11:03:01Z","timestamp":1769598181000},"page":"378-397","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Mechanistic Approach to Ferroptosis in Cancer and Neurological Diseases"],"prefix":"10.2174","volume":"27","author":[{"given":"Pranay","family":"Wal","sequence":"first","affiliation":[{"name":"PSIT-Pranveer Singh Institute of Technology Pharmacy, NH-19, Kanpur, Uttar Pradesh, 209305, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhijeet Singh","family":"Jadaun","sequence":"additional","affiliation":[{"name":"PSIT-Pranveer Singh Institute of Technology Pharmacy, NH-19, Kanpur, Uttar Pradesh, 209305, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakesh","family":"Verma","sequence":"additional","affiliation":[{"name":"Departmentof Pharmacology, Institute of Medical Science, BHU, Varanasi, 221005, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renuka Jyothi","family":"S","sequence":"additional","affiliation":[{"name":"Department ofBiotechnology and Genetics, School of Sciences, JAIN (Deemed to be University), Bangalore, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunil Kumar","family":"Dwivedi","sequence":"additional","affiliation":[{"name":"SriAurobindo Institute of Pharmacy, Indore MP, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunal Sharad","family":"Surwade","sequence":"additional","affiliation":[{"name":"KCT's R G Sapkal Institute of Pharmacy, Nashik, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1774-1043","authenticated-orcid":true,"given":"Namra","family":"Aziz","sequence":"additional","affiliation":[{"name":"PSIT-Pranveer Singh Institute of Technology Pharmacy, NH-19, Kanpur, Uttar Pradesh, 209305, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/cdd.2015.158","volume":"23","author":"Xie Y.","year":"2016","unstructured":"Xie Y.; Hou W.; Song X.; Ferroptosis: Process and function. Cell Death Differ  2016,23(3),369-79","journal-title":"Cell Death Differ"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/s41418-017-0012-4","volume":"25","author":"Galluzzi L.","year":"2018","unstructured":"Galluzzi L.; Vitale I.; Aaronson S.A.; Molecular mechanisms of cell death: Recommendations of the nomenclature committee on cell death 2018. Cell Death Differ  2018,25(3),486-541","journal-title":"Cell Death Differ"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1038\/ncb3064","volume":"16","author":"Friedmann Angeli J.P.","year":"2014","unstructured":"Friedmann Angeli J.P.; Schneider M.; Proneth B.; Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice. Nat Cell Biol  2014,16(12),1180-91","journal-title":"Nat Cell Biol"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"2996","DOI":"10.1073\/pnas.1819728116","volume":"116","author":"Wu Z.","year":"2019","unstructured":"Wu Z.; Geng Y.; Lu X.; Chaperone-mediated autophagy is involved in the execution of ferroptosis. Proc Natl Acad Sci USA  2019,116(8),2996-3005","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"1904197","DOI":"10.1002\/adma.201904197","volume":"31","author":"Liang C.","year":"2019","unstructured":"Liang C.; Zhang X.; Yang M.; Dong X.; Recent progress in ferroptosis inducers for cancer therapy. Adv Mater  2019,31(51),1904197","journal-title":"Adv Mater"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"4551","DOI":"10.1021\/ja411006a","volume":"136","author":"Skouta R.","year":"2014","unstructured":"Skouta R.; Dixon S.J.; Wang J.; Ferrostatins inhibit oxidative lipid damage and cell death in diverse disease models. J Am Chem Soc  2014,136(12),4551-6","journal-title":"J Am Chem Soc"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nature14344","volume":"520","author":"Jiang L.","year":"2015","unstructured":"Jiang L.; Kon N.; Li T.; Ferroptosis as a p53-mediated activity during tumour suppression. Nature  2015,520(7545),57-62","journal-title":"Nature"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.cell.2013.12.010","volume":"156","author":"Yang W.S.","year":"2014","unstructured":"Yang W.S.; SriRamaratnam R.; Welsch M.E.; Regulation of ferroptotic cancer cell death by GPX4. Cell  2014,156(1-2),317-31","journal-title":"Cell"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","volume":"149","author":"Dixon S.J.","year":"2012","unstructured":"Dixon S.J.; Lemberg K.M.; Lamprecht M.R.; Ferroptosis: An iron-dependent form of nonapoptotic cell death. Cell  2012,149(5),1060-72","journal-title":"Cell"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1177\/10738584221100183","volume":"29","author":"David S.","year":"2023","unstructured":"David S.; Ryan F.; Jhelum P.; Kroner A.; Ferroptosis in neurological disease. Neuroscientist  2023,29(5),591-615","journal-title":"Neuroscientist"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"8773","DOI":"10.1073\/pnas.1105941108","volume":"108","author":"Shaw A.T.","year":"2011","unstructured":"Shaw A.T.; Winslow M.M.; Magendantz M.; Selective killing of K-ras mutant cancer cells by small molecule inducers of oxidative stress. Proc Natl Acad Sci USA  2011,108(21),8773-8","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"4900","DOI":"10.1111\/jcmm.14511","volume":"23","author":"Xu T.","year":"2019","unstructured":"Xu T.; Ding W.; Ji X.; Molecular mechanisms of ferroptosis and its role in cancer therapy. J Cell Mol Med  2019,23(8),4900-12","journal-title":"J Cell Mol Med"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12943-020-1138-4","volume":"19","author":"Li X.","year":"2020","unstructured":"Li X.; He S.; Ma B.; Autophagy and autophagy-related proteins in cancer. Mol Cancer  2020,19(1),12","journal-title":"Mol Cancer"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1042\/BCJ20210854","volume":"479","author":"Lossi L.","year":"2022","unstructured":"Lossi L.; The concept of intrinsic versus extrinsic apoptosis. Biochem J  2022,479(3),357-84","journal-title":"Biochem J"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"684","DOI":"10.3390\/cancers13040684","volume":"13","author":"Della Torre L.","year":"2021","unstructured":"Della Torre L.; Nebbioso A.; Stunnenberg H.G.; Martens J.H.A.; Carafa V.; Altucci L.; The role of necroptosis: Biological relevance and its involvement in cancer. Cancers  2021,13(4),684","journal-title":"Cancers"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/s41419-020-2724-5","volume":"11","author":"Noguchi M.","year":"2020","unstructured":"Noguchi M.; Hirata N.; Tanaka T.; Suizu F.; Nakajima H.; Chiorini J.A.; Autophagy as a modulator of cell death machinery. Cell Death Dis  2020,11(7),517","journal-title":"Cell Death Dis"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"39","DOI":"10.3892\/wasj.2020.40","volume":"2","author":"Yan G.","year":"2020","unstructured":"Yan G.; Elbadawi M.; Efferth T.; Multiple cell death modalities and their key features (Review). World Acad Sci J  2020,2(2),39-48","journal-title":"World Acad Sci J"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"748925","DOI":"10.3389\/fcell.2021.748925","volume":"9","author":"Shi Z.Z.","year":"2021","unstructured":"Shi Z.Z.; Tao H.; Fan Z.W.; Song S.J.; Bai J.; Prognostic and immunological role of key genes of ferroptosis in pan-cancer. Front Cell Dev Biol  2021,9,748925","journal-title":"Front Cell Dev Biol"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1038\/s41576-022-00562-w","volume":"24","author":"Yamamoto H.","year":"2023","unstructured":"Yamamoto H.; Zhang S.; Mizushima N.; Autophagy genes in biology and disease. Nat Rev Genet  2023,24(6),382-400","journal-title":"Nat Rev Genet"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"9385","DOI":"10.3390\/ijms24119385","volume":"24","author":"Bragina E.Y.","year":"2023","unstructured":"Bragina E.Y.; Gomboeva D.E.; Saik O.V.; Apoptosis genes as a key to identification of inverse comorbidity of huntington\u2019s disease and cancer. Int J Mol Sci  2023,24(11),9385","journal-title":"Int J Mol Sci"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/s41419-022-04927-1","volume":"13","author":"Wang D.","year":"2022","unstructured":"Wang D.; Tang L.; Zhang Y.; Regulatory pathways and drugs associated with ferroptosis in tumors. Cell Death Dis  2022,13(6),544","journal-title":"Cell Death Dis"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.bulcan.2020.11.004","volume":"108","author":"Cao W.","year":"2021","unstructured":"Cao W.; Li J.; Yang K.; Cao D.; An overview of autophagy: Mechanism, regulation and research progress. Bull Cancer  2021,108(3),304-22","journal-title":"Bull Cancer"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1158\/2159-8290.CD-20-0789","volume":"11","author":"Koren E.","year":"2021","unstructured":"Koren E.; Fuchs Y.; Modes of regulated cell death in cancer. Cancer Discov  2021,11(2),245-65","journal-title":"Cancer Discov"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"8765","DOI":"10.3390\/ijms21228765","volume":"21","author":"Reichert C.O.","year":"2020","unstructured":"Reichert C.O.; de Freitas F.A.; Sampaio-Silva J.; Ferroptosis mechanisms involved in neurodegenerative diseases. Int J Mol Sci  2020,21(22),8765","journal-title":"Int J Mol Sci"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/j.tcb.2020.02.009","volume":"30","author":"Stockwell B.R.","year":"2020","unstructured":"Stockwell B.R.; Jiang X.; Gu W.; Emerging mechanisms and disease relevance of ferroptosis. Trends Cell Biol  2020,30(6),478-90","journal-title":"Trends Cell Biol"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.freeradbiomed.2020.02.027","volume":"152","author":"Ursini F.","year":"2020","unstructured":"Ursini F.; Maiorino M.; Lipid peroxidation and ferroptosis: The role of GSH and GPx4. Free Radic Biol Med  2020,152,175-85","journal-title":"Free Radic Biol Med"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"7038","DOI":"10.1111\/febs.16059","volume":"289","author":"Liu J.","year":"2022","unstructured":"Liu J.; Kang R.; Tang D.; Signaling pathways and defense mechanisms of ferroptosis. FEBS J  2022,289(22),7038-50","journal-title":"FEBS J"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1021\/jacsau.2c00681","volume":"3","author":"Do Q.","year":"2023","unstructured":"Do Q.; Zhang R.; Hooper G.; Xu L.; Differential contributions of distinct free radical peroxidation mechanisms to the induction of ferroptosis. JACS Au  2023,3(4),1100-17","journal-title":"JACS Au"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"449","DOI":"10.3390\/ijms24010449","volume":"24","author":"Rochette L.","year":"2022","unstructured":"Rochette L.; Dogon G.; Rigal E.; Zeller M.; Cottin Y.; Vergely C.; Lipid peroxidation and iron metabolism: Two cornerstones in the homeostasis control of ferroptosis. Int J Mol Sci  2022,24(1),449","journal-title":"Int J Mol Sci"},{"key":"ref=30","volume":"93","author":"Li Z.","year":"2023","unstructured":"Li Z.; Lange M.; Dixon S.J.; Olzmann J.A.; Lipid quality control and ferroptosis: From concept to mechanism. Annu Rev Biochem  2023,93","journal-title":"Annu Rev Biochem"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"101683","DOI":"10.1016\/j.xcrp.2023.101683","volume":"4","author":"Do Q.","year":"2023","unstructured":"Do Q.; Xu L.; How do different lipid peroxidation mechanisms contribute to ferroptosis? Cell Rep Phys Sci  2023,4(12),101683","journal-title":"Cell Rep Phys Sci"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/s41581-023-00689-x","volume":"19","author":"Bay\u0131r H.","year":"2023","unstructured":"Bay\u0131r H.; Dixon S.J.; Tyurina Y.Y.; Kellum J.A.; Kagan V.E.; Ferroptotic mechanisms and therapeutic targeting of iron metabolism and lipid peroxidation in the kidney. Nat Rev Nephrol  2023,19(5),315-36","journal-title":"Nat Rev Nephrol"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.chembiol.2020.03.014","volume":"27","author":"Bay\u0131r H.","year":"2020","unstructured":"Bay\u0131r H.; Anthonymuthu T.S.; Tyurina Y.Y.; Achieving life through death: Redox biology of lipid peroxidation in ferroptosis. Cell Chem Biol  2020,27(4),387-408","journal-title":"Cell Chem Biol"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/s41419-021-04490-1","volume":"13","author":"Zhang S.","year":"2022","unstructured":"Zhang S.; Xin W.; Anderson G.J.; Double-edge sword roles of iron in driving energy production versus instigating ferroptosis. Cell Death Dis  2022,13(1),40","journal-title":"Cell Death Dis"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/s41571-020-00462-0","volume":"18","author":"Chen X.","year":"2021","unstructured":"Chen X.; Kang R.; Kroemer G.; Tang D.; Broadening horizons: The role of ferroptosis in cancer. Nat Rev Clin Oncol  2021,18(5),280-296","journal-title":"Nat Rev Clin Oncol"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.7150\/ijbs.66917","volume":"18","author":"Zuo Y.B.","year":"2022","unstructured":"Zuo Y.B.; Zhang Y.F.; Zhang R.; Ferroptosis in cancer progression: Role of noncoding RNAs. Int J Biol Sci  2022,18(5),1829-43","journal-title":"Int J Biol Sci"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1007\/s13577-022-00699-0","volume":"35","author":"Valashedi M.R.","year":"2022","unstructured":"Valashedi M.R.; Bamshad C.; Najafi-Ghalehlou N.; Non-coding RNAs in ferroptotic cancer cell death pathway: Meet the new masters. Hum Cell  2022,35(4),972-94","journal-title":"Hum Cell"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"126911","DOI":"10.1016\/j.jtemb.2021.126911","volume":"70","author":"Qi R.","year":"2022","unstructured":"Qi R.; Bai Y.; Wei Y.; Liu N.; Shi B.; The role of non-coding RNAs in ferroptosis regulation. J Trace Elem Med Biol  2022,70,126911","journal-title":"J Trace Elem Med Biol"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"686906","DOI":"10.3389\/fcell.2021.686906","volume":"9","author":"Zhi Y.","year":"2021","unstructured":"Zhi Y.; Gao L.; Wang B.; Ren W.; Liang K.X.; Zhi K.; Ferroptosis holds novel promise in treatment of cancer mediated by non-coding RNAs. Front Cell Dev Biol  2021,9,686906","journal-title":"Front Cell Dev Biol"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1186\/s12935-022-02699-4","volume":"22","author":"Deng B.","year":"2022","unstructured":"Deng B.; Xiang J.; Liang Z.; Luo L.; Identification and validation of a ferroptosis-related gene to predict survival outcomes and the immune microenvironment in lung adenocarcinoma. Cancer Cell Int  2022,22(1),292","journal-title":"Cancer Cell Int"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1038\/s41419-020-02939-3","volume":"11","author":"Gai C.","year":"2020","unstructured":"Gai C.; Liu C.; Wu X.; MT1DP loaded by folate-modified liposomes sensitizes erastin-induced ferroptosis via regulating miR-365a-3p\/NRF2 axis in non-small cell lung cancer cells. Cell Death Dis  2020,11(9),751","journal-title":"Cell Death Dis"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1093\/abbs\/gmaa180","volume":"53","author":"Hou Y.","year":"2021","unstructured":"Hou Y.; Cai S.; Yu S.; Lin H.; Metformin induces ferroptosis by targeting miR-324-3p\/GPX4 axis in breast cancer. Acta Biochim Biophys Sin  2021,53(3),333-41","journal-title":"Acta Biochim Biophys Sin"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"3965","DOI":"10.2147\/DDDT.S332847","volume":"15","author":"He G.N.","year":"2021","unstructured":"He G.N.; Bao N.R.; Wang S.; Xi M.; Zhang T.H.; Chen F.S.; Ketamine induces ferroptosis of liver cancer cells by targeting lncRNA PVT1\/miR-214-3p\/GPX4. Drug Des Devel Ther  2021,15,3965-78","journal-title":"Drug Des Devel Ther"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"675555","DOI":"10.3389\/fcell.2021.675555","volume":"9","author":"Zheng J.","year":"2021","unstructured":"Zheng J.; Zhou Z.; Qiu Y.; A prognostic ferroptosis-related lncRNAs signature associated with immune landscape and radiotherapy response in glioma. Front Cell Dev Biol  2021,9,675555","journal-title":"Front Cell Dev Biol"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"8725","DOI":"10.1002\/cam4.4398","volume":"10","author":"Zhang S.","year":"2021","unstructured":"Zhang S.; Sun J.; Gu M.; Wang G.; Wang X.; Circular RNA: A promising new star for the diagnosis and treatment of colorectal cancer. Cancer Med  2021,10(24),8725-40","journal-title":"Cancer Med"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.ymthe.2020.09.024","volume":"29","author":"Wang Z.","year":"2021","unstructured":"Wang Z.; Chen X.; Liu N.; A nuclear long non-coding RNA LINC00618 accelerates ferroptosis in a manner dependent upon apoptosis. Mol Ther  2021,29(1),263-74","journal-title":"Mol Ther"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"101211","DOI":"10.1016\/j.redox.2019.101211","volume":"24","author":"Zhang X.","year":"2019","unstructured":"Zhang X.; Du L.; Qiao Y.; Ferroptosis is governed by differential regulation of transcription in liver cancer. Redox Biol  2019,24,101211","journal-title":"Redox Biol"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/s41422-020-00441-1","volume":"31","author":"Tang D.","year":"2021","unstructured":"Tang D.; Chen X.; Kang R.; Kroemer G.; Ferroptosis: Molecular mechanisms and health implications. Cell Res  2021,31(2),107-25","journal-title":"Cell Res"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"719187","DOI":"10.3389\/fcell.2021.719187","volume":"9","author":"Wang Y.","year":"2021","unstructured":"Wang Y.; Qiu S.; Wang H.; Transcriptional repression of ferritin light chain increases ferroptosis sensitivity in lung adenocarcinoma. Front Cell Dev Biol  2021,9,719187","journal-title":"Front Cell Dev Biol"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.freeradbiomed.2018.05.074","volume":"133","author":"Kang R.","year":"2019","unstructured":"Kang R.; Kroemer G.; Tang D.; The tumor suppressor protein p53 and the ferroptosis network. Free Radic Biol Med  2019,133,162-8","journal-title":"Free Radic Biol Med"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.ccell.2024.03.011","volume":"42","author":"Lei G.","year":"2024","unstructured":"Lei G.; Zhuang L.; Gan B.; The roles of ferroptosis in cancer: Tumor suppression, tumor microenvironment, and therapeutic interventions. Cancer Cell  2024,42(4),513-34","journal-title":"Cancer Cell"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"124","DOI":"10.3389\/fendo.2018.00124","volume":"9","author":"Gnanapradeepan K.","year":"2018","unstructured":"Gnanapradeepan K.; Basu S.; Barnoud T.; Budina-Kolomets A.; Kung C.P.; Murphy M.E.; The p53 tumour suppressor is involved in the control of metabolism and ferroptosis. Front Endocrinol  2018,9,124","journal-title":"Front Endocrinol"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1016\/j.bbrc.2016.08.124","volume":"478","author":"Yuan H.","year":"2016","unstructured":"Yuan H.; Li X.; Zhang X.; Kang R.; Tang D.; Identification of ACSL4 as a biomarker and contributor of ferroptosis. Biochem Biophys Res Commun  2016,478(3),1338-43","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"2960","DOI":"10.1080\/15384101.2020.1838781","volume":"19","author":"Ma Y.","year":"2020","unstructured":"Ma Y.; Han F.; Min J.; Lin W.; Energy metabolism as a regulator of ferroptosis. Cell Cycle  2020,19(22),2960-2962","journal-title":"Cell Cycle"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"117","DOI":"10.2174\/1566523219666190628152137","volume":"19","author":"Xia X.","year":"2019","unstructured":"Xia X.; Fan X.; Zhao M.; Zhu P.; The relationship between ferroptosis and tumours: A novel landscape for therapeutic approach. Curr Gene Ther  2019,19(2),117-124","journal-title":"Curr Gene Ther"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"2106568","DOI":"10.1002\/smll.202106568","volume":"18","author":"Zhou A.","year":"2022","unstructured":"Zhou A.; Fang T.; Chen K.; Xu Y.; Chen Z.; Ning X.; Biomimetic activator of sonodynamic ferroptosis amplifies inherent peroxidation for improving the treatment of breast cancer. Small  2022,18(12),2106568","journal-title":"Small"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"706650","DOI":"10.3389\/fmolb.2021.706650","volume":"8","author":"Bartolacci C.","year":"2021","unstructured":"Bartolacci C.; Andreani C.; El-Gammal Y.; Scaglioni P.P.; Lipid metabolism regulates oxidative stress and ferroptosis in RAS-driven cancers: A perspective on cancer progression and therapy. Front Mol Biosci  2021,8,706650","journal-title":"Front Mol Biosci"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"157","DOI":"10.3892\/ijo.2022.5447","volume":"61","author":"Liu X.","year":"2022","unstructured":"Liu X.; Hai Y.; Dong J.; Realgar-induced KRAS mutation lung cancer cell death via KRAS\/Raf\/MAPK mediates ferroptosis. Int J Oncol  2022,61(6),157","journal-title":"Int J Oncol"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"923915","DOI":"10.3389\/fonc.2022.923915","volume":"12","author":"Andreani C.","year":"2022","unstructured":"Andreani C.; Bartolacci C.; Scaglioni P.P.; Ferroptosis: A specific vulnerability of RAS-driven cancers? Front Oncol  2022,12,923915","journal-title":"Front Oncol"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s11010-020-03821-8","volume":"473","author":"Wu X.","year":"2020","unstructured":"Wu X.; Liu C.; Li Z.; Regulation of GSK3\u03b2\/Nrf2 signaling pathway modulated erastin-induced ferroptosis in breast cancer. Mol Cell Biochem  2020,473(1-2),217-28","journal-title":"Mol Cell Biochem"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"101107","DOI":"10.1016\/j.redox.2019.101107","volume":"23","author":"Dodson M.","year":"2019","unstructured":"Dodson M.; Castro-Portuguez R.; Zhang DD.; NRF2 plays a critical role in mitigating lipid peroxidation and ferroptosis. Redox Biol  2019,23,101107","journal-title":"Redox Biol"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"31189","DOI":"10.1073\/pnas.2017152117","volume":"117","author":"Yi J.","year":"2020","unstructured":"Yi J.; Zhu J.; Wu J.; Thompson C.B.; Jiang X.; Oncogenic activation of PI3K-AKT-mTOR signaling suppresses ferroptosis via SREBP-mediated lipogenesis. Proc Natl Acad Sci USA  2020,117(49),31189-97","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/s41417-020-0182-y","volume":"28","author":"Liu Y.","year":"2021","unstructured":"Liu Y.; Wang Y.; Liu J.; Kang R.; Tang D.; Interplay between MTOR and GPX4 signaling modulates autophagy-dependent ferroptotic cancer cell death. Cancer Gene Ther  2021,28(1-2),55-63","journal-title":"Cancer Gene Ther"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"111328","DOI":"10.1016\/j.cellsig.2024.111328","volume":"122","author":"Liu X.Q.","year":"2024","unstructured":"Liu X.Q.; Shi M.Z.; Bai Y.T.; Hypoxia and ferroptosis. Cell Signal  2024,122,111328","journal-title":"Cell Signal"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1038\/s41392-022-01080-1","volume":"7","author":"Luo Z.","year":"2022","unstructured":"Luo Z.; Tian M.; Yang G.; Hypoxia signaling in human health and diseases: Implications and prospects for therapeutics. Signal Transduct Target Ther  2022,7(1),218","journal-title":"Signal Transduct Target Ther"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"300","DOI":"10.3390\/biology11020300","volume":"11","author":"Bouhamida E.","year":"2022","unstructured":"Bouhamida E.; Morciano G.; Perrone M.; The interplay of hypoxia signalling on mitochondrial dysfunction and inflammation in cardiovascular diseases and cancer: From molecular mechanisms to therapeutic approaches. Biology  2022,11(2),300","journal-title":"Biology"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"8938","DOI":"10.1002\/anie.202016872","volume":"60","author":"Xue C.","year":"2021","unstructured":"Xue C.; Li M.; Liu C.; NIR\u2010actuated remote activation of ferroptosis in target tumour cells through a photothermally responsive iron\u2010chelated biopolymer nanoplatform. Angew Chem Int Ed  2021,60(16),8938-47","journal-title":"Angew Chem Int Ed"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"1704007","DOI":"10.1002\/adma.201704007","volume":"30","author":"Shen Z.","year":"2018","unstructured":"Shen Z.; Song J.; Yung B.C.; Zhou Z.; Wu A.; Chen X.; Emerging strategies of cancer therapy based on ferroptosis. Adv Mater  2018,30(12),1704007","journal-title":"Adv Mater"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"323","DOI":"10.3892\/ol.2019.11066","volume":"19","author":"Li Y.","year":"2020","unstructured":"Li Y.; Yan H.; Xu X.; Liu H.; Wu C.; Zhao L.; Erastin\/sorafenib induces cisplatin-resistant non-small cell lung cancer cell ferroptosis through inhibition of the Nrf2\/xCT pathway. Oncol Lett  2020,19(1),323-33","journal-title":"Oncol Lett"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"9271","DOI":"10.3390\/ijms22179271","volume":"22","author":"Kinowaki Y.","year":"2021","unstructured":"Kinowaki Y.; Taguchi T.; Onishi I.; Kirimura S.; Kitagawa M.; Yamamoto K.; Overview of ferroptosis and synthetic lethality strategies. Int J Mol Sci  2021,22(17),9271","journal-title":"Int J Mol Sci"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1002\/bab.2096","volume":"69","author":"Wu Z.","year":"2022","unstructured":"Wu Z.; Zhong M.; Liu Y.; Application of natural products for inducing ferroptosis in tumor cells. Biotechnol Appl Biochem  2022,69(1),190-7","journal-title":"Biotechnol Appl Biochem"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13045-020-01016-8","volume":"14","author":"Ding Y.","year":"2021","unstructured":"Ding Y.; Chen X.; Liu C.; Identification of a small molecule as inducer of ferroptosis and apoptosis through ubiquitination of GPX4 in triple negative breast cancer cells. J Hematol Oncol  2021,14(1),19","journal-title":"J Hematol Oncol"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1158\/1535-7163.MCT-21-0728","volume":"21","author":"Li J.","year":"2022","unstructured":"Li J.; Lama R.; Galster S.L.; Small-molecule MMRi62 induces ferroptosis and inhibits metastasis in pancreatic cancer via degradation of ferritin heavy chain and mutant p53. Mol Cancer Ther  2022,21(4),535-45","journal-title":"Mol Cancer Ther"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s40364-021-00338-0","volume":"9","author":"Wu S.","year":"2021","unstructured":"Wu S.; Zhu C.; Tang D.; Dou Q.P.; Shen J.; Chen X.; The role of ferroptosis in lung cancer. Biomark Res  2021,9(1),82","journal-title":"Biomark Res"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.bbrc.2021.06.088","volume":"569","author":"Liang Z.","year":"2021","unstructured":"Liang Z.; Zhao W.; Li X.; Wang L.; Meng L.; Yu R.; Cisplatin synergizes with PRLX93936 to induce ferroptosis in non-small cell lung cancer cells. Biochem Biophys Res Commun  2021,569,79-85","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"8872","DOI":"10.1038\/s41598-023-35978-9","volume":"13","author":"Kim J.W.","year":"2023","unstructured":"Kim J.W.; Min D.W.; Kim D.; GPX4 overexpressed non-small cell lung cancer cells are sensitive to RSL3-induced ferroptosis. Sci Rep  2023,13(1),8872","journal-title":"Sci Rep"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1080\/08923973.2022.2160731","volume":"45","author":"Wang L.","year":"2023","unstructured":"Wang L.; Wang J.; Chen L.; TIMP1 represses sorafenib-triggered ferroptosis in colorectal cancer cells by activating the PI3K\/Akt signaling pathway. Immunopharmacol Immunotoxicol  2023,45(4),419-25","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.freeradbiomed.2022.01.009","volume":"180","author":"Zhang W.","year":"2022","unstructured":"Zhang W.; Jiang B.; Liu Y.; Xu L.; Wan M.; Bufotalin induces ferroptosis in non-small cell lung cancer cells by facilitating the ubiquitination and degradation of GPX4. Free Radic Biol Med  2022,180,75-84","journal-title":"Free Radic Biol Med"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"14","DOI":"10.2174\/0118744710262369231110065230","volume":"17","author":"Zefrei F.J.","year":"2024","unstructured":"Zefrei F.J.; Shormij M.; Dastranj L.; Ferroptosis inducers as promising radiosensitizer agents in cancer radiotherapy. Curr Radiopharm  2024,17(1),14-29","journal-title":"Curr Radiopharm"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"105206","DOI":"10.1016\/j.chemphyslip.2022.105206","volume":"245","author":"Thangavelu P.","year":"2022","unstructured":"Thangavelu P.; Sundaram V.; Gunasekaran K.; Development of optimized novel liposome loaded with 6-gingerol and assessment of its therapeutic activity against NSCLC in vitro and in vivo experimental models. Chem Phys Lipids  2022,245,105206","journal-title":"Chem Phys Lipids"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1016\/j.molmed.2021.06.014","volume":"27","author":"Xu H.","year":"2021","unstructured":"Xu H.; Ye D.; Ren M.; Zhang H.; Bi F.; Ferroptosis in the tumor microenvironment: Perspectives for immunotherapy. Trends Mol Med  2021,27(9),856-67","journal-title":"Trends Mol Med"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1002\/cac2.12250","volume":"42","author":"Zhao L.","year":"2022","unstructured":"Zhao L.; Zhou X.; Xie F.; Ferroptosis in cancer and cancer immunotherapy. Cancer Commun  2022,42(2),88-116","journal-title":"Cancer Commun"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"9937","DOI":"10.7150\/thno.65480","volume":"11","author":"Luo L.","year":"2021","unstructured":"Luo L.; Wang H.; Tian W.; Targeting ferroptosis-based cancer therapy using nanomaterials: Strategies and applications. Theranostics  2021,11(20),9937-52","journal-title":"Theranostics"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"2481","DOI":"10.1021\/acsabm.2c00199","volume":"5","author":"Zhu L.","year":"2022","unstructured":"Zhu L.; Meng D.; Wang X.; Chen X.; Ferroptosis-driven nanotherapeutics to reverse drug resistance in tumour microenvironment. ACS Appl Bio Mater  2022,5(6),2481-506","journal-title":"ACS Appl Bio Mater"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1007\/s13238-021-00841-y","volume":"12","author":"Lei G.","year":"2021","unstructured":"Lei G.; Mao C.; Yan Y.; Zhuang L.; Gan B.; Ferroptosis, radiotherapy, and combination therapeutic strategies. Protein Cell  2021,12(11),836-857","journal-title":"Protein Cell"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1158\/2159-8290.CD-19-0338","volume":"9","author":"Lang X.","year":"2019","unstructured":"Lang X.; Green M.D.; Wang W.; Radiotherapy and immunotherapy promote tumoral lipid oxidation and ferroptosis via synergistic repression of SLC7A11. Cancer Discov  2019,9(12),1673-85","journal-title":"Cancer Discov"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1007\/s11033-022-08048-y","volume":"50","author":"Xu Y.","year":"2023","unstructured":"Xu Y.; Zhao J.; Zhao Y.; The role of ferroptosis in neurodegenerative diseases. Mol Biol Rep  2023,50(2),1655-61","journal-title":"Mol Biol Rep"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"1005182","DOI":"10.3389\/fncel.2022.1005182","volume":"16","author":"Ji Y.","year":"2022","unstructured":"Ji Y.; Zheng K.; Li S.; Insight into the potential role of ferroptosis in neurodegenerative diseases. Front Cell Neurosci  2022,16,1005182","journal-title":"Front Cell Neurosci"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"267","DOI":"10.3389\/fnins.2020.00267","volume":"14","author":"Song X.","year":"2020","unstructured":"Song X.; Long D.; Nrf2 and ferroptosis: A new research direction for neurodegenerative diseases. Front Neurosci  2020,14,267","journal-title":"Front Neurosci"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"659402","DOI":"10.3389\/fnagi.2021.659402","volume":"13","author":"Paul B.D.","year":"2021","unstructured":"Paul B.D.; Neuroprotective roles of the reverse transsulfuration pathway in Alzheimer's disease. Front Aging Neurosci  2021,13,659402","journal-title":"Front Aging Neurosci"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1111\/bph.14446","volume":"176","author":"Sbodio J.I.","year":"2019","unstructured":"Sbodio J.I.; Snyder S.H.; Paul B.D.; Regulators of the transsulfuration pathway. Br J Pharmacol  2019,176(4),583-93","journal-title":"Br J Pharmacol"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"2881","DOI":"10.1080\/15384101.2015.1068479","volume":"14","author":"Jiang L.","year":"2015","unstructured":"Jiang L.; Hickman J.H.; Wang S.J.; Gu W.; Dynamic roles of p53-mediated metabolic activities in ROS-induced stress responses. Cell Cycle  2015,14(18),2881-2885","journal-title":"Cell Cycle"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.molcel.2015.06.011","volume":"59","author":"Gao M.","year":"2015","unstructured":"Gao M.; Monian P.; Quadri N.; Ramasamy R.; Jiang X.; Glutaminolysis and transferrin regulate ferroptosis. Mol Cell  2015,59(2),298-308","journal-title":"Mol Cell"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.redox.2016.12.010","volume":"11","author":"Roh J.L.","year":"2017","unstructured":"Roh J.L.; Kim E.H.; Jang H.; Shin D.; Nrf2 inhibition reverses the resistance of cisplatin-resistant head and neck cancer cells to artesunate-induced ferroptosis. Redox Biol  2017,11,254-62","journal-title":"Redox Biol"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1016\/j.freeradbiomed.2004.02.075","volume":"36","author":"Itoh K.","year":"2004","unstructured":"Itoh K.; Tong K.I.; Yamamoto M.; Molecular mechanism activating nrf2\u2013keap1 pathway in regulation of adaptive response to electrophiles. Free Radic Biol Med  2004,36(10),1208-1213","journal-title":"Free Radic Biol Med"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1002\/hep.29117","volume":"66","author":"Wang H.","year":"2017","unstructured":"Wang H.; An P.; Xie E.; Characterization of ferroptosis in murine models of hemochromatosis. Hepatology  2017,66(2),449-65","journal-title":"Hepatology"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.ymgme.2022.04.006","volume":"136","author":"Elhani I.","year":"2022","unstructured":"Elhani I.; Hentgen V.; Grateau G.; Georgin-Lavialle S.; Neurological manifestations in mevalonate kinase deficiency: A systematic review. Mol Genet Metab  2022,136(2),85-93","journal-title":"Mol Genet Metab"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.biopha.2017.04.038","volume":"90","author":"Saeedi Saravi S.S.","year":"2017","unstructured":"Saeedi Saravi S.S.; Saeedi Saravi S.S.; Khoshbin K.; Dehpour A.R.; Current insights into pathogenesis of Parkinson\u2019s disease: Approach to mevalonate pathway and protective role of statins. Biomed Pharmacother  2017,90,724-30","journal-title":"Biomed Pharmacother"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"10448","DOI":"10.1007\/s12035-024-04216-2","volume":"61","author":"Shi H.","year":"2024","unstructured":"Shi H.; Song L.; Wu Y.; Edaravone alleviates traumatic brain injury by inhibition of ferroptosis via FSP1 pathway. Mol Neurobiol  2024,61(12),10448-61","journal-title":"Mol Neurobiol"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"101502","DOI":"10.1016\/j.molmet.2022.101502","volume":"61","author":"Ou M.","year":"2022","unstructured":"Ou M.; Jiang Y.; Ji Y.; Role and mechanism of ferroptosis in neurological diseases. Mol Metab  2022,61,101502","journal-title":"Mol Metab"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/s41467-017-02593-y","volume":"9","author":"Wang H.","year":"2018","unstructured":"Wang H.; An P.; Xie E.; Wu Q.; Fang X.; Gao H.; Characterisation of ferroptosis in murine models of Parkinson\u2019s disease. Nat Commun  2018,9(1),81","journal-title":"Nat Commun"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1186\/s12906-023-03995-w","volume":"23","author":"Wu C.","year":"2023","unstructured":"Wu C.; Zhao L.; Guo Y.; Moxibustion treatment for Parkinson\u2019s disease: Study protocol for a randomized controlled trial. BMC Complement Med Ther  2023,23(1),193","journal-title":"BMC Complement Med Ther"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"101890","DOI":"10.1016\/j.pneurobio.2020.101890","volume":"196","author":"Mahoney-S\u00e1nchez L.","year":"2021","unstructured":"Mahoney-S\u00e1nchez L.; Bouchaoui H.; Ayton S.; Devos D.; Duce J.A.; Devedjian J.C.; Ferroptosis and its potential role in the physiopathology of parkinson's disease. Prog Neurobiol  2021,196,101890","journal-title":"Prog Neurobiol"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.molmed.2022.02.003","volume":"28","author":"Wang Z.L.","year":"2022","unstructured":"Wang Z.L.; Yuan L.; Li W.; Li J.Y.; Ferroptosis in Parkinson\u2019s disease: Glia\u2013neuron crosstalk. Trends Mol Med  2022,28(4),258-69","journal-title":"Trends Mol Med"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1111\/jnc.15519","volume":"159","author":"Jakaria M.","year":"2021","unstructured":"Jakaria M.; Belaidi A.A.; Bush A.I.; Ayton S.; Ferroptosis as a mechanism of neurodegeneration in Alzheimer\u2019s disease. J Neurochem  2021,159(5),804-25","journal-title":"J Neurochem"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.freeradbiomed.2018.09.033","volume":"133","author":"Masaldan S.","year":"2019","unstructured":"Masaldan S.; Bush A.I.; Devos D.; Rolland A.S.; Moreau C.; Striking while the iron is hot: Iron metabolism and ferroptosis in neurodegeneration. Free Radic Biol Med  2019,133,221-33","journal-title":"Free Radic Biol Med"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1007\/s12017-018-8518-6","volume":"21","author":"Mi Y.","year":"2019","unstructured":"Mi Y.; Gao X.; Xu H.; Cui Y.; Zhang Y.; Gou X.; The emerging roles of ferroptosis in Huntington\u2019s disease. Neuromolecular Med  2019,21(2),110-9","journal-title":"Neuromolecular Med"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"85","DOI":"10.3389\/fnins.2019.00085","volume":"13","author":"DeGregorio-Rocasolano N.","year":"2019","unstructured":"DeGregorio-Rocasolano N.; Mart\u00ed-Sistac O.; Gasull T.; Deciphering the iron side of stroke: Neurodegeneration at the crossroads between iron dyshomeostasis, excitotoxicity, and ferroptosis. Front Neurosci  2019,13,85","journal-title":"Front Neurosci"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"2300325","DOI":"10.1002\/advs.202300325","volume":"10","author":"Wang Y.","year":"2023","unstructured":"Wang Y.; Wu S.; Li Q.; Sun H.; Wang H.; Pharmacological inhibition of ferroptosis as a therapeutic target for neurodegenerative diseases and strokes. Adv Sci  2023,10(24),2300325","journal-title":"Adv Sci"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"e22830","DOI":"10.1002\/jbt.22830","volume":"35","author":"Vitalakumar D.","year":"2021","unstructured":"Vitalakumar D.; Sharma A.; Flora S.J.S.; Ferroptosis: A potential therapeutic target for neurodegenerative diseases. J Biochem Mol Toxicol  2021,35(8),e22830","journal-title":"J Biochem Mol Toxicol"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.brainresbull.2021.04.023","volume":"172","author":"Geng Z.","year":"2021","unstructured":"Geng Z.; Guo Z.; Guo R.; Ye R.; Zhu W.; Yan B.; Ferroptosis and traumatic brain injury. Brain Res Bull  2021,172,212-9","journal-title":"Brain Res Bull"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"590789","DOI":"10.3389\/fncel.2020.590789","volume":"14","author":"Tang S.","year":"2020","unstructured":"Tang S.; Gao P.; Chen H.; Zhou X.; Ou Y.; He Y.; The role of iron, its metabolism and ferroptosis in traumatic brain injury. Front Cell Neurosci  2020,14,590789","journal-title":"Front Cell Neurosci"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"731","DOI":"10.3390\/antiox12030731","volume":"12","author":"Cheng H.","year":"2023","unstructured":"Cheng H.; Wang P.; Wang N.; Neuroprotection of NRF2 against ferroptosis after traumatic brain injury in mice. Antioxidants  2023,12(3),731","journal-title":"Antioxidants"},{"key":"ref=114","doi-asserted-by":"publisher","first-page":"395","DOI":"10.3390\/antiox13040395","volume":"13","author":"Xu Y.","year":"2024","unstructured":"Xu Y.; Jia B.; Li J.; Li Q.; Luo C.; The interplay between ferroptosis and neuroinflammation in central neurological disorders. Antioxidants  2024,13(4),395","journal-title":"Antioxidants"},{"key":"ref=115","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s12943-022-01530-y","volume":"21","author":"Zhang C.","year":"2022","unstructured":"Zhang C.; Liu X.; Jin S.; Chen Y.; Guo R.; Ferroptosis in cancer therapy: A novel approach to reversing drug resistance. Mol Cancer  2022,21(1),47","journal-title":"Mol Cancer"},{"key":"ref=116","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1038\/s41392-023-01606-1","volume":"8","author":"Sun S.","year":"2023","unstructured":"Sun S.; Shen J.; Jiang J.; Wang F.; Min J.; Targeting ferroptosis opens new avenues for the development of novel therapeutics. Signal Transduct Target Ther  2023,8(1),372","journal-title":"Signal Transduct Target Ther"},{"key":"ref=117","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1038\/s41419-023-05930-w","volume":"14","author":"Chen Z.","year":"2023","unstructured":"Chen Z.; Wang W.; Abdul Razak S.R.; Han T.; Ahmad N.H.; Li X.; Ferroptosis as a potential target for cancer therapy. Cell Death Dis  2023,14(7),460","journal-title":"Cell Death Dis"},{"key":"ref=118","doi-asserted-by":"publisher","first-page":"e1036","DOI":"10.1002\/iid3.1036","volume":"11","author":"Wang S.","year":"2023","unstructured":"Wang S.; Lu Y.; Chi T.; Zhang Y.; Zhao Y.; Guo H.; Feng L.; Identification of ferroptosis-related genes in type 2 diabetes mellitus based on machine learning. Immun Inflamm Dis  2023,11(10),e1036","journal-title":"Immun Inflamm Dis"}],"container-title":["Current Drug Targets"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0113894501358981251124065950","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/250030\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0113894501358981251124065950","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T04:36:03Z","timestamp":1790915763000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/250030\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":118,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0113894501358981251124065950","relation":{},"ISSN":["1389-4501"],"issn-type":[{"value":"1389-4501","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Double blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2024-10-17","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-08-23","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-12","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-30","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}